Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Insmed starts Phase II muscular dystrophy trial for Iplex
The purpose of the Phase II study is to confirm the positive results obtained in the ongoing open-label study. The study will include 60 patients and will be
The purpose of the Phase II study is to confirm the positive results obtained in the ongoing open-label study. The study will include 60 patients and will be
The data was presented by Dr. David Morrow of the Timi Study Group at the American Heart Association Scientific Sessions in Orlando, Florida. Ranexa (ranolazine) is believed to
This clinical trial focused on the immunogenicity of a three-dose BioThrax (Anthrax Vaccine Adsorbed) regimen when used for post-exposure prophylaxis (PEP) in adults. The primary objective of the
This grant is part of the $22.6 million the Gates Foundation has granted to the University of North Carolina led consortium in 2006 to fund Phase III clinical
Under the collaboration, Epix has said, it is entitled to receive a $3 million milestone payment in the next 30 days. In August, Epix announced that it had
In this study, R7128 demonstrated potent antiviral activity and was generally safe and well-tolerated, and all 40 patients completed the study. R7128 is being developed in collaboration with
The studies, Enable 1 and Enable 2, will measure the ability of eltrombopag to raise platelet counts sufficiently enough to enable the initiation of antiviral therapy and to
Because Gardasil is designed to prevent HPV 6, 11, 16 and 18 disease, rather than treat an ongoing infection, the primary analysis of the study was conducted among
The in-licensing of Tarenflurbil broadens Nitec’s pipeline and underscores the company’s ambition to become a significant player focused on treating unmet medical needs in chronic inflammation and pain.
The results show that SPP100, the first-in-class direct renin inhibitor, further lowers proteinuria in diabetic patients, independent of blood pressure, when administered on top of losartan, a standard